Fundamentals of Obesity Treatment
Begin your obesity medicine learning with this introductory course.
Join this interactive, case-based learning experience from your home or office. Offered three times a year as an online course with live lectures and case studies – register today and earn up to 9.75 CME/CE.
Fundamentals of Obesity Treatment is a 1.5-day live, virtual course (up to 9.75 CME/CE) offering introductory education about the evidence-based approaches for evaluating, diagnosing, and treating obesity in a clinical setting. The content is appropriate for physicians, nurse practitioners, physician assistants, clinicians-in-training, and other healthcare providers who treat patients with the disease of obesity. The first day of the course includes lectures on the main topics of obesity treatment. The second day of the course features interactive case discussions utilizing the knowledge from the previous day.
An on-demand version (5.0 CME/CE) is available through the OMA Academy.
November 22-23, 2024
Fundamentals of Obesity Treatment | November 2024
This obesity medicine basics course helps students understand the importance of using a long-term approach to obesity treatment. Earn up to 9.75 CME/CE as you learn to recognize obesity as a disease with diverse etiologies.
Fundamentals Course Schedule
-
1:00–1:05 PM EDT - Welcome and Introduction
1:05–1:45 PM EDT - Understanding the Chronic Disease of Obesity (0.5 CME/CE)
1:45–2:30 PM EDT - Nutrition Therapy (.75 CME/CE)
2:30–3:00 PM EDT - Physical Activity Basics (0.5 CME/CE)
3:05–3:15 PM EDT - Break
3:15-4:15 PM EDT- Behavior Modification (1.0 CME/CE)
4:15-5:15 PM ET- Surgical Options (1.0 CME/CE)
5:15–5:25 PM EDT - Break
5:25–6:45 PM EDT - Elements of Pharmacotherapy (1.25 CME/CE)
6:45–7:00 PM EDT - Question and Answer Session (0.25 CME/CE)
-
10:00–10:15 AM EDT - Question and Answer and Introduction to Casework (0.25 CME/CE)
10:15–11:15 AM EDT - Case Discussion 1 (1 CME/CE)
11:15–11:30 AM EDT - Break
11:30 AM–12:30 PM EDT - Case Discussion 2 (1 CME/CE)
12:30–1:30 PM EDT - Case Discussion 3 (1 CME/CE)
1:30–2:00 PM EDT - Lunch
2:00–3:00 PM EDT - Case Discussion 4 (1 CME/CE)
3:00–3:15 PM EDT - Question and Answer and Conclusion (0.25 CME/CE)
Looking for an On-Demand Fundamentals Course?
Should you be unable to participate in any of our live virtual sessions for the Fundamentals of Obesity Treatment course, you have the option to access the on-demand version through the OMA Academy. Please note that, as the live component holds exceptional value, the case study sessions are exclusively available in the live course and are not part of the on-demand option. By enrolling in the on-demand Fundamentals course, you can still earn a maximum of 5 CME/CE credits
Group Pricing Available
Interested in Registering a Group?
OMA offers group pricing for the Fundamentals of Obesity Treatment course! Get 10% OFF 5 people, 20% OFF 6-10 people, and 25% OFF 11+ people. Contact OMA’s Membership Services to register your group.
Accreditation for the Fundamentals of Obesity Treatment Course
The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- The Obesity Medicine Association designates this live activity for a maximum of 9.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Education Support
This education activity has received support through an independent educational grant from Novo Nordisk, Inc.